Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN)

Historical Holders from Q2 2021 to Q3 2025

Symbol
DAWN on Nasdaq
Type / Class
Equity / COMMON STOCK
Shares outstanding
102M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
85.4M
Holdings value
$602M
% of all portfolios
0.002%
Grand Portfolio weight change
0%
Number of holders
169
Number of buys
83
Number of sells
-95
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 9.9% -11.8% $71.2M -$8.78M 10.1M -11% FMR LLC 30 Sep 2025
BlackRock, Inc. 5.8% +22% $38.1M $6.75M 5.85M +21.6% BlackRock, Inc. 30 Jun 2025

Institutional Holders of Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 85.4M $602M -$3.59M $7.05 169
2025 Q2 86.2M $560M -$67.6M $6.50 173
2025 Q1 94.1M $746M -$40.5M $7.93 183
2024 Q4 93.7M $1.19B -$5.88M $12.67 163
2024 Q3 92.1M $1.28B +$239M $13.93 165
2024 Q2 74.7M $1.03B +$17.4M $13.78 155
2024 Q1 72.8M $1.2B -$58.5M $16.52 147
2023 Q4 76.6M $1.12B -$50.2M $14.60 138
2023 Q3 77.5M $952M -$22.2M $12.27 127
2023 Q2 78.8M $941M +$208M $11.94 136
2023 Q1 61.2M $818M -$10.2M $13.37 122
2022 Q4 59.8M $1.29B -$37.7M $21.52 105
2022 Q3 60.3M $1.21B +$24M $20.03 87
2022 Q2 59.3M $1.06B +$303M $17.90 80
2022 Q1 43.3M $430M +$13.1M $9.92 66
2021 Q4 41.5M $698M +$75M $16.85 57
2021 Q3 19M $450M +$32.6M $23.73 43
2021 Q2 17.7M $401M +$401M $22.77 32